2080 Psoas and Masseter Sarcopenia as Predictors of Outcomes in Neurocritical Patients: A Systematic Review

View at publisher Summarise with VIRAT
Authors: Guilherme Linha Secco, Felipe Pereira, Luis Gustavo Biondi Soares, Enzo von Quednow, Murtaja Satea Shafeea, Noor Najah Noori, Kayla Brice, Kim wouters, Vitor Otavio Tenório Soares, Mateus Cordeiro Merlim da Silva, Edgar Daniel Guzmán-Ríos, Khaled H. Aal Ali
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Sarcopenia, a progressive skeletal muscle disorder, predicts unfavorable outcomes in neurocritical patients, including traumatic brain injury, with higher mortality rates compared to non-sarcopenic patients. METHODS: We followed PRISMA guidelines. Notable databases were utilized for sources. Baseline characteristics, sarcopenia rates, mortality rates, functional status after discharge, and ICU and hospital lengths of stay were recorded. We used Rayyan.ai for screening and ROBINS-I for quality assessment. Methodological quality was assessed via the AMSTAR 2 tool. RESULTS: Six articles were included, totaling 962 individuals, approximately 58% of whom were male. Weighted averages were calculated: age (66.3), masseter area (4.92), psoas area (16.38), and psoas index (5.76). All studies confirmed sarcopenia as a predictor of outcomes. Few data are available on the ICU and hospital LOS, but indirect measures, such as days free of the ICU, days free of ventilators and rates of pneumonia, suggest a relationship between masseter and psoas areas and the ICU/hospital LOS. Functional status was also a related outcome. Neurocritical and sarcopenic patients tend to have worse mRS and GOS scores, in addition to being discharged to a nursing facility. CONCLUSIONS: Masseter and psoas sarcopenia have emerged as critical predictors of poor outcomes in neurocritical patients. These markers should be integrated into neurocritical care for better risk stratification. However, to maximize their clinical utility, future research must focus on establishing standardized definitions, refining measurement techniques, and exploring potential therapeutic strategies to mitigate sarcopenia-related complications.

Fields of Study & Subjects

Nutrition and Health in Aging Intensive Care Unit Cognitive Disorders Clinical Nutrition and Gastroenterology

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
264–265
Publication date
26 March 2026
Language
EN